CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Matthew Baker, Colin Walsh |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 6.75p |
Change Today | -0.050p |
% Change | -0.74 % |
52 Week High | 10.20 |
52 Week Low | 2.90 |
Volume | 384,566 |
Shares Issued | 113.32m |
Market Cap | £7.65m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:09 | 40,000 @ 6.55p |
15:06 | 11 @ 7.00p |
14:12 | 2,862 @ 6.83p |
13:45 | 7 @ 7.00p |
12:32 | 100,000 @ 6.65p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research